24-Hour Abp Monitoring Of Blood Pressure In Patients With Chronic Heart Failure And The State Of Kidney Function
Keywords:
daily monitoring of blood pressure, chronic heart failure, decreased glomerular filtration rate
Abstract
The results of the study of the daily profile of blood pressure (BP) in 194 patients with chronic heart failure (CHF), depending on the glomerular filtration rate (GFR), are presented. It was found that the daily monitoring of blood pressure in patients with CHF can significantly increase the frequency of detection of potentially dangerous changes in blood pressure. Target BP is achieved only in 42.9% of patients with CHF and GFR<45.1 ml/min/1.73m2 and in 18.4% of patients with CHF and GFR>69.8 ml/min/1.73m2. Episodes of systolic arterial hypotension were detected in 51% of patients with CHF and GFR<45.1 ml/min/1.73 m2 and 26.5% of patients with CHF and GFR ≥69.8 ml/ min/1.73m2, episodes of chronic arterial hypotension were diagnosed in 71.4% of patients with CHF and GFR≤45.1 ml/min/1.73 m2 and 61,2% of patients with CHF and GFR ≥69.8 ml/min/1.73 m2 . The duration of systolic arterial hypotension during the day in patients with CHF correlates with the level of glycemia and the duration of diastolic arterial hypotension-with the age of patients.
References
Stam F., van Guldener C., Becker A. et al. Endothelial dysfunction contributes to renal function associated cardiovascular mortality in a population with mild renal insufficiency: the Hoom study. J. Am. Soc. Nephrol. 2006; 17(2): 537-45.
Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351 (13): 1296-305.
Agarwal R. Systolic hypertension in hemodialysis patients. Semin. Dial. 2003; 16: 208-13.
Farmer C.K., Goldsmith D.J., Cox J. et al. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol. Dial. Transplant. 1997; 12: 2301-7.
Oseaghdha C. M., Perkovic V., Lam T.H. et al. Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region. Hypertension. 2009; 54(3): 509-15
ESCAPE Trial Group, Wuhl E., Trivelli A. et al. Strict blood pressure control and progression of renal failure in children. N.Engl. J.Med. 2009;361(17): 1639-50
Andersen M.J., Khawandi W., Agarwal R. Home blood pressure monitoring in CKD. Am. J. Kidney Dis. 2005; 45: 994-1001.
Tomlinson L.A., Holt S.G., Leslie A. R. et al. Prevalence of ambulatory hypotension in elderly patients with CKD stages 3 and 4. Nephrol. Dial. Transplant. 2009; 24(12): 3751-5.
Redon J., Plancha E., Swift P.A. et al. Nocturnal blood pressure and progression to endstage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J. Hypertens. 2010; 28(3): 602-7.
Csiky B., Kovacs T., Wagner L., et al. Ambulatory blood pressure monitoring and progression in patients with Ig A nephropathy. Nephrol. Dial. Transplant. 1999; 14: 86-90.
Shin J., Kline S., Moore M. et al. Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure. J. Card. Fail. 2007; 13(8); 656-62.
Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН. Сердечная недостаточность. 2010; 57(1): 3-62.
Levey A.S., Coresh J., Balk E. et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med.2003; 139 (2): 137-47.
Суточное мониторирование артериального давления (методические вопросы). Рогоза А.Н., Никольский В.П., Ощепкова Е.В. и др. под ред. Г. Г. Арабидзе., О.Ю. Атыкова., 1997;
Ратова Л.Г., Дмитриев В.В., Толпыгина С.Н., Чазова И.Е., Суточное мониторирование артериального давления в клинической практике. Consilium Medicum. Артериальная гипертензия. 2001; 2(прил.); 3-14.
De la Sierra A., Redon J., Banegas J. R. et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patiens. Hypertension. 2009; 53(3): 466-72.
Prisant L.M. Blunted nocturnal decline in blood pressure. J. Clin. Hypertens.(Greenwich). 2004; 6(10): 594-7.
Kanbay M., Turgut F., Uyar M.E., et al., Causes and mechanisms of nondipping hypertension. Clin., Exp. Hypertens. 2008; 30(7): 585-97.
Fukuda M., Mizuno M., Yamanaka T., et al., Patiens with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension. 2008; 52(6): 1155-60.
Lee T.T. Chen J., Cohen D.J., Tsao L. The association between blood pressure and mortality in patients with heart failure. Am.Heart J. 2006; 151(1): 76-83.
Guder G., Frantz S., Bauersachs J. et al., Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ. Heart Fail. 2009; 2(6): 563-71.
Raphael C.E., Whinnett Z.I., Davies J.E. et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart. 2009; 95(1): 56-62.
Gheorghiade M., Abraham W.T., Albert N. M. et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. J.A.M.A. 24. 2006; 296(18): 2217-26.
Lee D.S., Ghosh N., Floras J.S. et al. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure. Circ. Heart Fail. 2009; 2: 616-23.
D’Agostino R.B., Belanger A.J., Kannel W.B., Cruickshank J.M., Relation Of low diastolic blood pressure to coronary heart disease death in presense of myocardial infarction: the Framingham Study. Br. Med. J. 1991; 303: 385-9.
Bangalore S., Qin J., Sloan S. et al. What is the optimal blood pressure in patients after acute coronary syndromes?. Relationship of blood pressure and cardiovascular events in the PR avastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010; 122(21): 2142-51.
Messerli F.H., Panjrath G.S. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J.Am. Coll. Cardiol. 2009; 54(20): 1827-34.
Routledge F.S., Mc. Fetridge-Durdle J.A., Dean C.R. et al. Night-time blood pressure patterns and target organ damage: a review. Can. J. Cardiol. 2007; 23(2): 132-8.
Hermida R.C., Ayala D.E., Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 2007; 59(9-10): 904-22.
Hoshide S., Kario K., Hoshide Y. et al. Associations between non-dipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens. 2003; 16(6): 434-8.
Davidson M. B., Hix J.K., Vidt D.G. et al. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch. Intern. Med. 2006; 166(8): 846-52.
Ingelsson E., Bjorklund-Bodegard K., Lind L. et al. Diurnal blood pressure pattern and risk of congestive heart failure. J.A.M.A. 2006; 295 (24): 2859-66.
Ksiazek A., Zalushka W. Sympathetic overactivity in uremia. J. Ren. Nutr. 2008; 18(1): 118-21.
Schlaich M.P., Socratous F., Hennebry S. et al. Sympathetic activation in chronic renal failure. J. Am. Soc. Nephrol. 2009; 20(5): 933-9.
Серов В.А., Шутов А.М., Сучков В.Н. и др. Прогностическое значение хронической болезни почек у больных хронической сердечной недостаточностью. Нефрология и диализ. 2008; №3-4: 214-8.
Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351 (13): 1296-305.
Agarwal R. Systolic hypertension in hemodialysis patients. Semin. Dial. 2003; 16: 208-13.
Farmer C.K., Goldsmith D.J., Cox J. et al. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol. Dial. Transplant. 1997; 12: 2301-7.
Oseaghdha C. M., Perkovic V., Lam T.H. et al. Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region. Hypertension. 2009; 54(3): 509-15
ESCAPE Trial Group, Wuhl E., Trivelli A. et al. Strict blood pressure control and progression of renal failure in children. N.Engl. J.Med. 2009;361(17): 1639-50
Andersen M.J., Khawandi W., Agarwal R. Home blood pressure monitoring in CKD. Am. J. Kidney Dis. 2005; 45: 994-1001.
Tomlinson L.A., Holt S.G., Leslie A. R. et al. Prevalence of ambulatory hypotension in elderly patients with CKD stages 3 and 4. Nephrol. Dial. Transplant. 2009; 24(12): 3751-5.
Redon J., Plancha E., Swift P.A. et al. Nocturnal blood pressure and progression to endstage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J. Hypertens. 2010; 28(3): 602-7.
Csiky B., Kovacs T., Wagner L., et al. Ambulatory blood pressure monitoring and progression in patients with Ig A nephropathy. Nephrol. Dial. Transplant. 1999; 14: 86-90.
Shin J., Kline S., Moore M. et al. Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure. J. Card. Fail. 2007; 13(8); 656-62.
Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН. Сердечная недостаточность. 2010; 57(1): 3-62.
Levey A.S., Coresh J., Balk E. et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med.2003; 139 (2): 137-47.
Суточное мониторирование артериального давления (методические вопросы). Рогоза А.Н., Никольский В.П., Ощепкова Е.В. и др. под ред. Г. Г. Арабидзе., О.Ю. Атыкова., 1997;
Ратова Л.Г., Дмитриев В.В., Толпыгина С.Н., Чазова И.Е., Суточное мониторирование артериального давления в клинической практике. Consilium Medicum. Артериальная гипертензия. 2001; 2(прил.); 3-14.
De la Sierra A., Redon J., Banegas J. R. et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patiens. Hypertension. 2009; 53(3): 466-72.
Prisant L.M. Blunted nocturnal decline in blood pressure. J. Clin. Hypertens.(Greenwich). 2004; 6(10): 594-7.
Kanbay M., Turgut F., Uyar M.E., et al., Causes and mechanisms of nondipping hypertension. Clin., Exp. Hypertens. 2008; 30(7): 585-97.
Fukuda M., Mizuno M., Yamanaka T., et al., Patiens with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension. 2008; 52(6): 1155-60.
Lee T.T. Chen J., Cohen D.J., Tsao L. The association between blood pressure and mortality in patients with heart failure. Am.Heart J. 2006; 151(1): 76-83.
Guder G., Frantz S., Bauersachs J. et al., Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ. Heart Fail. 2009; 2(6): 563-71.
Raphael C.E., Whinnett Z.I., Davies J.E. et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart. 2009; 95(1): 56-62.
Gheorghiade M., Abraham W.T., Albert N. M. et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. J.A.M.A. 24. 2006; 296(18): 2217-26.
Lee D.S., Ghosh N., Floras J.S. et al. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure. Circ. Heart Fail. 2009; 2: 616-23.
D’Agostino R.B., Belanger A.J., Kannel W.B., Cruickshank J.M., Relation Of low diastolic blood pressure to coronary heart disease death in presense of myocardial infarction: the Framingham Study. Br. Med. J. 1991; 303: 385-9.
Bangalore S., Qin J., Sloan S. et al. What is the optimal blood pressure in patients after acute coronary syndromes?. Relationship of blood pressure and cardiovascular events in the PR avastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010; 122(21): 2142-51.
Messerli F.H., Panjrath G.S. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J.Am. Coll. Cardiol. 2009; 54(20): 1827-34.
Routledge F.S., Mc. Fetridge-Durdle J.A., Dean C.R. et al. Night-time blood pressure patterns and target organ damage: a review. Can. J. Cardiol. 2007; 23(2): 132-8.
Hermida R.C., Ayala D.E., Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 2007; 59(9-10): 904-22.
Hoshide S., Kario K., Hoshide Y. et al. Associations between non-dipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens. 2003; 16(6): 434-8.
Davidson M. B., Hix J.K., Vidt D.G. et al. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch. Intern. Med. 2006; 166(8): 846-52.
Ingelsson E., Bjorklund-Bodegard K., Lind L. et al. Diurnal blood pressure pattern and risk of congestive heart failure. J.A.M.A. 2006; 295 (24): 2859-66.
Ksiazek A., Zalushka W. Sympathetic overactivity in uremia. J. Ren. Nutr. 2008; 18(1): 118-21.
Schlaich M.P., Socratous F., Hennebry S. et al. Sympathetic activation in chronic renal failure. J. Am. Soc. Nephrol. 2009; 20(5): 933-9.
Серов В.А., Шутов А.М., Сучков В.Н. и др. Прогностическое значение хронической болезни почек у больных хронической сердечной недостаточностью. Нефрология и диализ. 2008; №3-4: 214-8.
Published
2021-02-28
How to Cite
Munira Khusainova Alisherovna. (2021). 24-Hour Abp Monitoring Of Blood Pressure In Patients With Chronic Heart Failure And The State Of Kidney Function. Central Asian Journal of Medical and Natural Science, 2(1), 197-204. Retrieved from https://www.cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/103
Section
Articles
